| Bioactivity | Evenamide hydrochloride is an orally available voltage-gated sodium channel (VGSC) blocker (Ki=0.4 μM) for the research of schizophrenia. Evenamide hydrochloride shows efficacy in a broad spectrum of rodent models of psychosis, mania, depression, and aggressiveness[1][2]. |
| CAS | 1092977-06-4 |
| Formula | C16H27ClN2O2 |
| Molar Mass | 314.85 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Valentina Zuliani, et al. Advances in Design and Development of Sodium Channel Blockers. Ion Channels and Their Inhibitors pp 79-115. [2]. Faravelli, et al. P.3.f.022 Evenamide (formerly NW-3509) targets new mechanisms, and represents a new approach to the management of untreated symptoms in schizophrenia. |
Evenamide hydrochloride
CAS: 1092977-06-4 F: C16H27ClN2O2 W: 314.85
Evenamide hydrochloride is an orally availablevoltage-gated sodium channel (VGSC) blocker (Ki=0.4 μM) for the research
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.